A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Trials using oral dosing of labeled and unlabeled drug have demonstrated that the ... Patients included those inadequately controlled with bronchodilators alone (Trial 1), those already receiving ...

The drug was administered twice-daily using a ... phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator and anti-inflammatory properties in one compound.

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

Rubaab, an 8-year-old Noida student living in Delhi, has been using a nebuliser ever since he was a toddler. A nebulizer is a ...

Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...